SHERRIE GOULD: Open Payments
NPI 1154467975 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62,606 in 234 payments from 17 companies in 2025. Trend: 2023 $67,841 · 2024 $49,709 · 2025 $62,606
Speaker / faculty: $34,958Travel & lodging: $10,521Honoraria: $7,491Food & beverage: $5,422Consulting: $3,238Education: $977
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 80 | $31,069 |
| Merz Pharmaceuticals, LLC | 20 | $7,652 |
| MDD US Operations, LLC | 32 | $5,767 |
| Amneal Pharmaceuticals LLC | 15 | $5,381 |
| Boston Scientific Corporation | 16 | $5,284 |
| Medtronic, Inc. | 27 | $3,028 |
| Tanabe Pharma America, Inc. | 6 | $2,760 |
| ABBVIE INC. | 20 | $775 |
| Abbott Laboratories | 5 | $501 |
| Neurocrine BioSciences, Inc. | 4 | $202 |
Products named: NUPLAZID, INBRIJA, CREXONT, Vercise, Gocovri, PERCEPT PC BRAINSENSE, INFINITY, VYALEV.
Industry payments across CA — which companies pay providers there.
